Long Noncoding RNAs in the Prediction of Survival of Patients with Digestive Cancers
Turkish Journal of Gastroenterology · 2022
DOI: 10.5152/tjg.2022.22017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2022. Verfasst von Shu Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital,…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Adenocarcinoma, Pancreatic Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Long noncoding RNAs have been known to be involved in various cancers. This study aimed to find a long noncoding RNA signature to predict the prognostic risk of patients with digestive cancers, including esophageal carcinoma, stomach adenocarcinoma, liver hepatocellular carcinoma, and pancreatic adenocarcinoma.
Methods
After screening differentially expressed long noncoding RNAs in 4 digestive cancers from The Cancer Genome Atlas database, the prognostic significance of the above differentially expressed long noncoding RNAs was evaluated by Kaplan–Meier analysis. Target genes of the corresponding differentially expressed long noncoding RNAs were predicted by StarBase. We performed bioinformatics methods, including gene ontology annotation and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, to explore the role and molecular mechanisms of differentially expressed long noncoding RNAs and predicted target genes in tumor progression.
Results
A total of 4 differentially expressed long noncoding RNAs (AC093895.1, CASC9, LINC01980, and HOXC-AS2) with a significant prognostic value were identified. Moreover, 6 target genes were obtained. Also, functional enrichment analysis showed that these 4 DELs were mainly related to the regulation of mRNA metabolic process, regulation of RNA stability, mRNA binding, RNA localization, and spliceosome.
Conclusion
The prognostic differentially expressed long noncoding RNAs and target genes in the digestive cancers were obtained, which may provide a novel direction for treatment and prognosis improvement of digestive cancers. Cite this article as: Zhao S, Li P, Zhou G. Long noncoding RNAs in the prediction of survival of patients with digestive cancers. Turk J Gastroenterol. 2023; 34(1): 19-25.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Zitieren
APA
Zhao, S., Li, P., & Zhou, G. (2022). Long Noncoding RNAs in the Prediction of Survival of Patients with Digestive Cancers. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2022.22017
Vancouver
Zhao S, Li P, Zhou G. Long Noncoding RNAs in the Prediction of Survival of Patients with Digestive Cancers. Turkish Journal of Gastroenterology. 2022. doi:10.5152/tjg.2022.22017
BibTeX
@article{Zhao2022,
author = {Zhao, Shu and Li, Peng and Zhou, Gang},
title = {Long Noncoding RNAs in the Prediction of Survival of Patients with Digestive Cancers},
journal = {Turkish Journal of Gastroenterology},
year = {2022},
doi = {10.5152/tjg.2022.22017}
}
EUVIMED